Smarter Decisions,
Better Care

UpToDate synthesizes the most recent medical information into evidence-based practical recommendations clinicians trust to make the right point-of-care decisions.

  • Rigorous editorial process: Evidence-based treatment recommendations
  • World-Renowned physician authors: over 5,100 physician authors and editors around the globe
  • Innovative technology: integrates into the workflow; access from EMRs

Choose from the list below to learn more about subscriptions for a:


Subscribers log in here


Treatment of chronic eosinophilic pneumonia

INTRODUCTION

Chronic eosinophilic pneumonia (CEP) is a disorder characterized by an abnormal and marked accumulation of eosinophils in the lung [1]. CEP can often present as a fulminant illness with a constellation of symptoms including cough, fever, progressive breathlessness, weight loss, wheezing, and night sweats [2]. Other characteristics of CEP include the following:

  • Asthma accompanies, precedes, or subsequently occurs, in over 50 percent of cases [3]. A majority of patients are nonsmokers.
  • The finding of bilateral peripheral or pleural-based opacities described as the "photographic negative" of pulmonary edema is virtually pathognomonic for the disease when seen on chest radiograph (image 1) or high resolution computed tomography (picture 1) [4].
  • Peripheral blood eosinophilia (>6 percent), a very high sedimentation rate, C-reactive protein, iron deficiency anemia, and thrombocytosis are all common laboratory abnormalities [5].
  • Bronchoalveolar lavage (BAL) eosinophilia of greater than 25 percent is suggestive of CEP [5,6]. These eosinophils appear to be activated, as evidenced by the presence of several different markers of activation, including increased release of eosinophil proteins [7]. Serial BAL examinations may be helpful in following the course of the disease but is rarely indicated [6].
  • Histopathologic findings are characterized by interstitial and alveolar eosinophils and histiocytes, including multinucleated giant cells. Fibrosis is minimal, and bronchiolitis obliterans with organizing pneumonia is a common associated finding (picture 2).

In this review, the treatment of chronic eosinophilic pneumonia and response to therapy are discussed. The evaluation and differential diagnosis of eosinophilic lung diseases, in general, and an approach to acute eosinophilic pneumonia are described separately. (See "Causes of pulmonary eosinophilia" and "Idiopathic acute eosinophilic pneumonia".)

TREATMENT

Fewer than 10 percent of patients with CEP spontaneously recover or improve. In addition, CEP occasionally leads to physiologically important, irreversible fibrosis [8], although death secondary to CEP is extremely unusual. As a result, therapy is indicated once alternative diagnoses of eosinophilic infiltration of the lung are excluded (particularly infectious causes).

Patients with CEP are uniformly responsive to intravenous or oral glucocorticoids. Thus, an alternative diagnosis should be entertained if a patient is steroid-resistant.

       

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Aug 2014. | This topic last updated: Sep 19, 2012.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2014 UpToDate, Inc.
References
Top
  1. Allen JN, Davis WB. Eosinophilic lung diseases. Am J Respir Crit Care Med 1994; 150:1423.
  2. Jederlinic PJ, Sicilian L, Gaensler EA. Chronic eosinophilic pneumonia. A report of 19 cases and a review of the literature. Medicine (Baltimore) 1988; 67:154.
  3. Marchand E, Etienne-Mastroianni B, Chanez P, et al. Idiopathic chronic eosinophilic pneumonia and asthma: how do they influence each other? Eur Respir J 2003; 22:8.
  4. Gaensler EA, Carrington CB. Peripheral opacities in chronic eosinophilic pneumonia: the photographic negative of pulmonary edema. AJR Am J Roentgenol 1977; 128:1.
  5. Matsuse H, Shimoda T, Fukushima C, et al. Diagnostic problems in chronic eosinophilic pneumonia. J Int Med Res 1997; 25:196.
  6. Danel, C, Israel-Biet, D, Costabel, U, et al. The clinical role of BAL in rare pulmonary diseases. Eur Respir Rev 1991; 2:83.
  7. Janin A, Torpier G, Courtin P, et al. Segregation of eosinophil proteins in alveolar macrophage compartments in chronic eosinophilic pneumonia. Thorax 1993; 48:57.
  8. Yoshida K, Shijubo N, Koba H, et al. Chronic eosinophilic pneumonia progressing to lung fibrosis. Eur Respir J 1994; 7:1541.
  9. Marchand E, Reynaud-Gaubert M, Lauque D, et al. Idiopathic chronic eosinophilic pneumonia. A clinical and follow-up study of 62 cases. The Groupe d'Etudes et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM"O"P). Medicine (Baltimore) 1998; 77:299.
  10. Minakuchi M, Niimi A, Matsumoto H, et al. Chronic eosinophilic pneumonia: treatment with inhaled corticosteroids. Respiration 2003; 70:362.
  11. Ebara H, Ikezoe J, Johkoh T, et al. Chronic eosinophilic pneumonia: evolution of chest radiograms and CT features. J Comput Assist Tomogr 1994; 18:737.
  12. Deviller P, Gruart V, Prin L, et al. Detection of an eosinophil derived neurotoxin in the urine of a patient with idiopathic chronic eosinophilic pneumonia. Clin Chim Acta 1991; 201:105.
  13. Demedts M, De Man F. Circulating immune complexes in chronic eosinophilic pneumonia. Acta Clin Belg 1991; 46:75.
  14. Ogushi F, Ozaki T, Kawano T, Yasuoka S. PGE2 and PGF2 alpha content in bronchoalveolar lavage fluid obtained from patients with eosinophilic pneumonia. Chest 1987; 91:204.
  15. Naughton M, Fahy J, FitzGerald MX. Chronic eosinophilic pneumonia. A long-term follow-up of 12 patients. Chest 1993; 103:162.
  16. Durieu J, Wallaert B, Tonnel AB. Long-term follow-up of pulmonary function in chronic eosinophilic pneumonia. Groupe d'Etude en Pathologie Interstitielle de la Société de Pathologie Thoracique du Nord. Eur Respir J 1997; 10:286.
  17. Golstein MA, Steinfeld S. Chronic eosinophilic pneumonia followed by Churg-Strauss syndrome. Rev Rhum Engl Ed 1996; 63:624.